May 15, 2020
The Ministry of Health, Labor and Welfare (MHLW) will ask Novartis Pharma to swiftly start supplying its spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec) following its listing scheduled for late this month, Senior Health Vice Minister Hisashi Inatsu...read more